Patents Assigned to Reinnervate Limited
  • Retinoid compounds and their use
    Patent number: 8293803
    Abstract: The invention relates to retinoid compounds of the formula (I): wherein V is a hydrophobic group; W is a non-polyenic linker; and X is a polar group comprising a hydrogen bond donor; or a salt thereof, and to the use of such compounds in the control of cell differentiation.
    Type: Grant
    Filed: August 28, 2007
    Date of Patent: October 23, 2012
    Assignee: Reinnervate Limited
    Inventors: Stefan Przyborski, Andrew Whiting, Todd Marder
  • RETINOID COMPOUNDS AND THEIR USE
    Publication number: 20100093088
    Abstract: The invention relates to retinoid compounds of the formula (I): wherein V is a hydrophobic group; W is a non-polyenic linker; and X is a polar group comprising a hydrogen bond donor; or a salt thereof, and to the use of such compounds in the control of cell differentiation.
    Type: Application
    Filed: August 28, 2007
    Publication date: April 15, 2010
    Applicant: REINNERVATE LIMITED
    Inventors: Stefan Przyborski, Andrew Whiting, Todd Marder
  • SUBSTRATE FOR THE GROWTH OF CULTURED CELLS IN THREE DIMENSIONS
    Publication number: 20100048411
    Abstract: We describe a cell culture substrate comprising a polymerised high internal phase emulsion polymer adapted and modified for use in the routine culture of cells in three dimensions; typically mammalian cells and the use of the substrate in a cell culture system for investigation and analysis of proliferation, differentiation and function of cells.
    Type: Application
    Filed: April 24, 2007
    Publication date: February 25, 2010
    Applicant: REINNERVATE LIMITED
    Inventors: Stefan Alexander Przyborski, Neil Cameron